The utility of fecal corticosterone metabolites and animal welfare assessment protocols as predictive parameters of tumor development and animal welfare in a murine xenograft model

In Vivo

Volumn 27, Issue 2, 2013, Pages 189-196

  Jacobsen, Kirsten Rosenmaj ^a   Jørgensen, Pernille ^b   Pipper, Christian Bressen ^a   Steffensen, Astrid Margrethe ^b   Hau, Jann ^a   Abelson, Klas S P ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b Pipeline Biotech A/S   (Denmark)

Author keywords

Cancer; Fecal corticosterone; Mice; Welfare

Indexed keywords

CORTICOSTERONE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CANCER GROWTH; CANCER PAIN; CARCINOGENESIS; CONTROLLED STUDY; EXPERIMENTAL ANIMAL WELFARE; EXPERIMENTAL MOUSE; FECES ANALYSIS; FLUID INTAKE; FOOD INTAKE; MALE; METABOLITE; MOUSE; NON INVASIVE MEASUREMENT; NONHUMAN; PREDICTIVE VALUE; PROSTATE CANCER; STRESS; TUMOR MODEL; TUMOR VOLUME; TUMOR XENOGRAFT;

EID: 84876891552     PISSN: 0258851X     EISSN: 17917549     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Workman P, Aboagye EO, Balkwill F, Balmain A, Bruder G, Chaplin DJ, Double JA, Everitt J, Farningham DAH, Glennie MJ, Kelland LR, Robinson V, Stratford IJ, Tozer GM, Watson S, Wedge SR, Eccles SA, Navaratnam V and Ryder S: Guidelines for the welfare and use of animals in cancer research. Br J Cancer 102: 1555-1577, 2010.
2. Levy MH: Drug therapy: Pharmacologic treatment of cancer pain. N Engl J Med 335: 1124-1132, 1996.
3. Schiffer SP: Animal welfare and colony management in cancer research. Breast Cancer Res Tr 46: 313-331, 1997.
4. Ferin M: Stress and the reproductive cycle. J Clin Endocr Metab 84: 1768-1774, 1999.
5. Gartner K, Buttner D, Dohler K, Friedel R, Lindena J and Trautschold I: Stress response of rats to handling and experimental procedures. Lab Anim 14: 267-274, 1980.
6. Padgett DA and Glaser R: How stress influences the immune response. Trends Immunol 24: 444-448, 2003.
7. Retana-Marquez S, Bonilla-Jaime H, Vazquez-Palacios G, Martinez-Garcia R and Velazquez-Moctezuma J: Changes in masculine sexual behavior, corticosterone and testosterone in response to acute and chronic stress in male rats. Horm Behav 44: 327-337, 2003.
8. Thaker PH, Han LY, Kamat AA, Arevalo JM, Takahashi R, Lu CH, Jennings NB, Armaiz-Pena G, Bankson JA, Ravoori M, Merritt WM, Lin YG, Mangala LS, Kim TJ, Coleman RL, Landen CN, Li Y, Felix E, Sanguino AM, Newman RA, Lloyd M, Gershenson DM, Kundra V, Lopez-Berestein G, Lutgendorf SK, Cole SW and Sood AK: Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma. Nat Med 12: 939-944, 2006.
9. Reiche EMV, Nunes SOV and Morimoto HK: Stress, depression, the immune system, and cancer. Lancet Oncol 5: 617-625, 2004.
10. Giraldi T, Perissin L, Zorzet S, Piccini P and Rapozzi V: Effects of stress on tumor growth and metastasis in mice bearing Lewis lung carcinoma. Eur J Cancer Clin On 25: 1583-1587, 1989.
11. Wu WJ, Murata J, Hayashi K, Yamaura T, Mitani N and Saiki I: Social isolation stress impairs the resistance of mice to experimental liver metastasis of murine colon 26-L5 carcinoma cells. Biol Pharm Bul 24: 772-776, 2001.
12. Roughan JV, Flecknell PA and Davies BR: Behavioural assessment of the effects of tumour growth in rats and the influence of the analgesics carprofen and meloxicam. Lab Anim 38: 286-296, 2004.
13. Banning A, Sjogren P and Henriksen H: Pain causes in 200 patients referred to a multidisciplinary cancer pain clinic. Pain 45: 45-48, 1991.
14. Grond S, Zech D, Diefenbach C and Bischoff A: Prevalence and pattern of symptoms in patients with cancer pain - a prospective evaluation of 1635 cancer-patients referred to a pain clinic. J Pain Symptom Manag 9: 372-382, 1994.
15. Commitee on Recognition and Alleviation of Pain in Laboratory Animals: Recognition and Alleviation of Pain in Laboratory Animals. Washington DC, National Academy Press, 2009.
16. Wright-Williams SL, Courade JP, Richardson CA, Roughan JV and Flecknell PA: Effects of vasectomy surgery and meloxicam treatment on faecal corticosterone levels and behaviour in two strains of laboratory mouse. Pain 130: 108-118, 2007.
17. Swenson J, Gun S, Radjavi A, Kaur T and Reilly CM: Clinical efficacy of buprenorphine to minimize distress in MRL/Ipr mice. Eur J Pharmacol 567: 67-76, 2007.
18. Peterson NC: Behavioral, clinical, and physiologic analysis of mice used for ascites monoclonal antibody production. Comparative Med 50: 516-526, 2000.
19. Sundbom R, Jacobsen KR, Kalliokoski O, Hau J and Abelson KSP: Postoperative corticosterone levels in plasma and feces of mice subjected to permanent catheterization and automated blood sampling. In Vivo 25: 335-342, 2011.
20. Kohn DF, Martin TE, Foley PL, Morris TH, Swindle MM, Vogler GA and Wixson SK: Guidelines for the assessment and management of pain in rodents and rabbits. J Am Assoc Lab Anim Sci 46: 97-108, 2007.
21. Jacobsen KR, Kalliokoski O, Teilmann AC, Hau J and Abelson KSP: Postsurgical food and water consumption, fecal corticosterone metabolites, and behavior as noninvasive measures of pain in vasectomized BALB/c mice. J Am Assoc Lab Anim Sci 51: 1-7, 2012.
22. Royo F, Björk N, Carlsson HE and Hau J: Impact of chronic catheterization and automated blood sampling (Accusampler) on serum corticosterone and fecal immunoreactive corticosterone metabolites and immunoglobulin A in male rats. J Endocrinol 180: 145-153, 2004.
23. Lepschy M, Touma C, Hruby R and Palme R: Non-invasive measurement of adrenocortical activity in male and female rats. Lab Anim 41: 372-387, 2007.
24. Kalliokoski O, Abelson KSP, Koch J, Boschian A, Thormose SF, Fauerby N, Rasmussen RS, Johansen FF and Hau J: the effect of voluntarily ingested buprenorphine on rats subjected to surgically induced global cerebral ischaemia. In Vivo 24: 641- 646, 2010.
25. Siswanto H, Hau J, Carlsson HE, Goldkuhl R and Abelson KSP: Corticosterone concentrations in blood and excretion in faeces after ACTH administration in male Sprague-Dawley rats. In Vivo 22: 435-440, 2008.
26. Carlsson HE, Lyberg K, Royo F and Hau J: Quantification of stress sensitive markers in single fecal samples do not accurately predict excretion of these in the pig. Res Vet Sci 82: 423-428, 2007.
27. Molony V, Kent JE, Hosie BD and Graham MJ: Reduction in pain suffered by lambs at castration. Vet J 153: 205-213, 1997.
28. Stafford KJ, Mellor DJ, Todd SE, Bruce RA and Ward RN: Effects of local anaesthesia or local anaesthesia plus a nonsteroidal anti-inflammatory drug on the acute cortisol response of calves to five different methods of castration. Res Vet Sci 73: 61-70, 2002.
29. Carlsson HE, Royo F, Faheem S, Tufvesson M and Hau J: Separation of pair-housed roosters is associated with transient increased corticosteroid excretion. Res Vet Sci 86: 183-187, 2009.
30. Paramastri Y, Royo F, Eberova J, Carlsson HE, Sajuthi D, Fernstrom AL, Pamungkas J and Hau J: Urinary and fecal immunoglobulin A, cortisol and 11-17 dioxoandrostanes, and serum cortisol in metabolic cage housed female cynomolgus monkeys (Macaca fascicularis). J Med Primatol 36: 355-364, 2007.
31. Whitten PL, Stavisky RC, Aureli F and Russel E: Response of fecal cortisol to stress in captive chimpanzees (Pan troglodytes). Am J Primatol 44: 57-69, 1998.
32. Wasser SK, Hunt KE, Brown JL, Cooper K, Crockett CM, Bechert U, Millspaugh JJ, Larson S and Monfort SL: A generalized fecal glucocorticoid assay for use in a diverse array of nondomestic mammalian and avian species. Gen Comp Endocr 120: 260-275, 2000.
33. Kalliokoski O, Hau J, Jacobsen KR, Schumacher-Petersen C and Abelson KSP: Distribution and time course of corticosterone excretion in faeces and urine of female mice with varying systemic concentrations. Gen Comp Endocr 168: 450-454, 2010.
34. Touitou Y, Bogdan A, Levi F, Benavides M and Auzeby A: Disruption of the circadian patterns of serum cortisol in breast and ovarian cancer patients: Relationships with tumour marker antigens. Br J Cancer 74: 1248-1252, 1996.
35. Hilf R, Burnett FF and Borman A: the effect of sarcoma-180 and other stressing agents upon adrenal and plasma corticosterone in mice. Cancer Res 20: 1389-1393, 1960.
36. Burstein S and Nadel EM: Corticosteroid production rates in strain 2 guinea pigs following L2C/Nb leukemia transplantation. Cancer Res 27: 2119-2122, 1967.
37. Supplementail data for Staunton J, Slonim DK, Coller HA, Tamayo P, Angelo MJ, Park J,Scherf U, Lee JK, Reinholdt WO, Weinstein JN, Mesirov JP, Lander ES and Golub TR. http://www.broadinstitute.org/mpr/NCI60/. Last accessed January 2013.
38. Institute for Laboratory Animal Research: Guide for the Care and Use of Laboratory Animals. Washington (DC), National Academies Press, pp. 1-124, 2011.
39. Workman P, Balmain A, Hickman JA, McNally NJ, Rohas AM, Mitchison NA, Pierrepoint CG, Raymond R, Rowlatt C, Stephens TC and Wallace J: UKCCCR guidelines for the welfare of animals in experimental neoplasia. Lab Anim 22: 195-201, 1988.
40. Nemzek JA, Xiao HY, Minard AE, Bolgos GL and Remick DG: Humane endpoints in shock research. Shock 21: 17-25, 2004.
41. Acred P, Hennessey TD, Macarthurclark JA, Merrikin DJ, Ryan DM, Smulders HC, Troke PF, Wilson RG and Straughan DW: Guidelines for the welfare of animals in rodent protection tests. Lab Anim 28: 13-18, 1994.
42. Stasiak KL, Maul D, French E, Hellyer PW and Vandewoude S: Species-specific assessment of pain in laboratory animals. Contemp Top Lab Anim 42: 13-20, 2003.
43. Hawkins P: Recognizing and assessing pain, suffering and distress in laboratory animals: A survey of current practice in the UK with recommendations. Lab Anim 36: 378-395, 2002.
44. Morton DB: Humane endpoints in animal experimentation for biomedical research: ethical, legal and practical aspects. In: Humane Endpoints in Animal Experiments for Biomedical Research. Hendriksen CFM and Morton DB (eds.). London, Royal Society of Medicine Press, pp. 5-12,1999.
45. Osterlund C and Spencer RL: Corticosterone pretreatment suppresses stress-induced hypothalamic pituitary adrenal axis activity via multiple actions that vary with time, site of action, and de novo protein synthesis. J Endocrinol 208: 311-322, 2011.
46. Marc V, Donelli MG, Bartosek I, Guaitani A, Standen S and Morselli PL: Metabolism of exogeneous cortisol in tumobearing rats. Eur J C 10: 437-443, 1974.
47. Nakamura J and Yakata M: Determination of urinary cortisol and 6-beta-hydroxycortisol by high-performance liquid chromatography. Clin Chim Acta 149: 215-224, 1985.
48. Werk EE, Sholiton LJ and Macgee J: Altered cortisol metabolism in advanced cancer and other terminal illnesses - excretion of 6-hydroxycortisol. Metabolism 13: 1425-1438, 1964.
49. Bamberg E, Palme R and Meingassner JG: Excretion of corticosteroid metabolites in urine and faeces of rats. Lab Anim 35: 307-314, 2001.
50. Kelley KW, Bluthe RM, Dantzer R, Zhou JH, Shen WH, Johnson RW and Broussard SR: Cytokine-induced sickness behavior. Brain Behav Immun 17: 112-118, 2003.
51. Laviano A, Meguid MM and Rossi-Fanelli F: Cancer anorexia: Clinical implications, pathogenesis, and therapeutic strategies. Lancet Oncol 4: 686-694, 2003.
52. Theologides A: Cancer cachexia. Cancer 43: 2004-2012, 1979.